IDT’s strong quarter delivers growth

Pharmaceutical manufacturer IDT Australia is seeing a surge in sales as demand for medical cannabis products rises and companies seek out more capable contract development and manufacturing organisations (CDMO). The Melbourne company told investors that revenues increased for the fourth quarter, with 4QFY23 revenue up 200 percent on the previous corresponding period to $2.4 million.…

We are closer than ever to being able to 3D print medicines. Here’s why that’s important

By Amirali Popat, The University of Queensland; Jared Miles, The University of Queensland, and Liam Krueger, The University of Queensland 3D-printed medicine could be the future of personalised healthcare, with research now suggesting printed tablets have reached a sufficient quality to match the standards set for conventionally manufactured tablets. Our new study, published in the…